| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;94:3023-3025.)
© 1996 American Heart Association, Inc.
Articles |
Alcohol and Heart Disease
Key Words: AHA Medical/Scientific Statements • coronary disease • alcohol
 |
Introduction |
|---|
 Top Introduction Measurements of Alcohol...Relation Between Alcohol...Protective Effects of Alcohol...Mechanisms for Cardioprotective...RecommendationsReferences |
|---|
Any advice about the consumption of alcohol must take into account not only the complex relation between alcohol and cardiovascular disease but also the well-known association of heavy consumption of alcohol with a large number of health risks.1 One approach would be to recommend no consumption of alcohol. However, a large number of recent observational studies have consistently demonstrated a reduction in coronary heart disease (CHD) with moderate consumption of alcohol.2 3 Any prohibition of alcohol would then deny such persons a potentially sizable health benefit. This advisory examines the complex relation between alcohol and coronary heart disease and offers recommendations for the responsible use of alcohol.
|
Measurements of Alcohol Consumption |
|---|
|
TopIntroductionMeasurements of Alcohol...Relation Between Alcohol...Protective Effects of Alcohol...Mechanisms for Cardioprotective...RecommendationsReferences |
|---|
Many beverages contain alcohol in varying amounts, necessitating standardization of the quantity of alcohol contained in various drinks. In general, the amount of absolute alcohol in grams is determined by the number of beverages consumed per day times the amount of alcohol in each beverage. In general, a 12-ounce bottle of beer, a 4-ounce glass of wine, and a 1 1/2-ounce shot of 80-proof spirits all contain the same amount of alcohol (one half ounce). Each of these is considered a "drink equivalent."4 Recent studies have tried to determine whether specific beverages have unique protective or deleterious effects. The interpretation of this research is complex because one person often consumes several types of beverages.
|
Relation Between Alcohol Consumption and Total Mortality |
|---|
|
TopIntroductionMeasurements of Alcohol...Relation Between Alcohol...Protective Effects of Alcohol...Mechanisms for Cardioprotective...RecommendationsReferences |
|---|
A large number of observational studies have consistently demonstrated a J-shaped relation between alcohol consumption and total mortality.5 This relation appears to hold in men and women who are middle aged or older.6 7 8 9 The lowest mortality occurs in those who consume one or two drinks per day.10 In teetotalers or occasional drinkers, the rates are higher than in those consuming one or two drinks per day. In persons who consume three or more drinks per day, total mortality climbs rapidly with increasing numbers of drinks per day.
A number of studies have dissected the J-shaped curve into specific diseases. It is clear that a stepwise decline in CHD death occurs with increasing drinks per day. Because CHD accounts for one third or more of total deaths, those with no alcohol consumption have higher total mortality than those drinking one to two drinks per day.11 On the other hand, mortality due to a large number of other diseases increases with an increasing number of drinks consumed per day. Diseases related to heavy consumption of alcohol and alcoholism include stroke,7 alcoholic cardiomyopathy,12 several kinds of cancer, cirrhosis, and pancreatitis, as well as accidents, suicide, and homicide. It should be noted that heavy consumption of alcohol is a major cause of hypertension,13 so that the diseases related to hypertension, such as stroke, are generally related to alcohol consumption. Heavy consumption of alcohol also appears to affect heart muscle and possibly arterial tissues directly. Alcoholic cardiomyopathy is a common diagnosis in long-term alcoholics. While the relative and absolute risks of these diseases are negligible at one or two drinks per day, the mortality rates rise sharply.14 The J-shaped distribution for total mortality is then the sum of the protective effect on CHD mortality and the detrimental effect of high levels of consumption on these other causes of death.
|
Protective Effects of Alcohol Against CHD |
|---|
|
TopIntroductionMeasurements of Alcohol...Relation Between Alcohol...Protective Effects of Alcohol...Mechanisms for Cardioprotective...RecommendationsReferences |
|---|
More than a dozen prospective studies have demonstrated a consistent, strong, dose-response relation between increasing alcohol consumption and decreasing incidence of CHD. The data are similar in men and women in a number of different geographic and ethnic groups. Consumption of one or two drinks per day is associated with a reduction in risk of approximately 30% to 50%.15 Studies of coronary narrowings defined by cardiac catheterization or autopsy show a reduction in atherosclerosis in persons who consume moderate amounts of alcohol. In general, the inverse association is independent of potential confounders, such as diet and cigarette smoking. Concerns that the association could be an artifact due to cessation of alcohol consumption in persons who already have CHD have largely been disproved.16 No clinical trials have been performed to test the alcohol-CHD relation. However, the large numbers of observational studies support a true protective effect of moderate consumption of alcohol.
|
Mechanisms for Cardioprotective Effects of Moderate Consumption of Alcohol |
|---|
|
TopIntroductionMeasurements of Alcohol...Relation Between Alcohol...Protective Effects of Alcohol...Mechanisms for Cardioprotective...RecommendationsReferences |
|---|
Recent analyses suggest that approximately 50% of the protective effect of alcohol is mediated through increased levels of HDL cholesterol.17 HDL removes cholesterol from the arterial wall and transports it back to the liver and probably has several other protective effects on the arterial system. A number of epidemiological studies and small clinical trials have demonstrated that moderate consumption of alcohol raises HDL cholesterol levels.18 19 20 When HDL cholesterol was added to computer models predictive of CHD, about half the benefit of alcohol in protecting against CHD could be attributed to its effect on HDL levels.21 22
A number of other mechanisms have been proposed to explain the other half of the protective effect of alcohol against CHD. One or two alcoholic drinks per day apparently do not affect other major risk factors, such as LDL cholesterol and blood pressure. Several studies have suggested that alcohol may affect blood clotting, either by causing the blood to clot less avidly through effects on coagulation factors and platelets or by enhancing the ability of the blood to break up clots when they form.23 24 These studies are supported by epidemiological data that suggest that acute alcohol consumption causes a short-term beneficial effect in protection against CHD in addition to long-term effects. Other studies have focused on the nonalcoholic components of alcoholic beverages, particularly in red wine and dark beer, which may have antioxidant properties.25 26 27 However, the epidemiological evidence favoring one type of beverage over another is inconsistent, possibly because of large differences in diet, smoking, and other risk behaviors among drinkers.28 Again, at least half of the inverse association between alcohol and CHD appears to be directly linked to alcohol through increased HDL cholesterol levels.
|
Recommendations |
|---|
|
TopIntroductionMeasurements of Alcohol...Relation Between Alcohol...Protective Effects of Alcohol...Mechanisms for Cardioprotective...RecommendationsReferences |
|---|
It is unlikely that a randomized, controlled trial of alcohol consumption will ever be performed to establish a direct link between alcohol consumption and reduction in CHD and to define the risks and benefits of encouraging consumption of alcohol. In lieu of this scientific base, a number of scientific facts can be brought to bear on the development of recommendations about alcohol consumption.2 29 30 31 32 First, the beneficial effects of alcohol are limited to one or two drinks per day. Second, heavier consumption is related to a number of health problems. Third, it is clear that persons with medical and social conditions made worse by alcohol should not consume any alcohol whatsoever, including persons with prior diagnoses of hypertriglyceridemia, pancreatitis, liver disease, porphyria, uncontrolled hypertension, and congestive heart failure. Pregnant women and persons on certain medications that interact with alcohol should also refrain from consumption. Persons with a personal or strong family history of alcoholism are at risk for alcohol addiction and should avoid all alcoholic beverages.
These facts preclude widespread public health recommendations to either encourage or prohibit alcohol consumption. In the United States 100 000 excess deaths can be attributed to alcohol-related diseases each year.11 On the other hand, if current consumers of alcohol all abstained from drinking, approximately 80 000 excess deaths would occur.2 Most of the excess deaths due to alcohol occur in people younger than 45 years, whereas deaths reduced by alcohol are generally in age groups with high CHD rates, ie, 45 years or older. In either case, general public health education messages about alcohol may be difficult to develop, so that they target only persons for whom moderate consumption of alcohol would have a positive cost-benefit ratio.
Therefore, the following recommendations may be made for the individual patient who is considering beginning or continuing to drink alcohol.
1. Consult a physician for an assessment of the benefits and risks of alcohol consumption. Persons with a personal or family history of alcoholism, hypertriglyceridemia, pancreatitis, liver disease, certain blood disorders, heart failure, and uncontrolled hypertension, as well as pregnant women and persons on certain medications that interact with alcohol, should not consume any alcohol. Any recommendations should be tailored to the individual patient's risks and potential benefits.
2. If no contraindications to alcohol consumption are present, moderate consumption of alcohol (one or two drinks per day) may be considered safe.
3. Alcohol should never be consumed when operating machinery or motor vehicles.
4. The risks and benefits of alcohol consumption should be reviewed periodically as part of regular medical care. In the event of excess consumption, problem drinking, or deleterious consequences of drinking, recommendations for alcohol consumption should be revised.
5. Adolescents and young adults should be targeted for assessment and advice before potentially deleterious habits of consumption become established.
|
Footnotes |
|---|
A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Avenue, Dallas, TX 75231-4596. Ask for reprint No. 71-0097.
"Alcohol and Heart Disease" was approved by the Science Advisory and Coordinating Committee of the American Heart Association in July 1996.
|
References |
|---|
|
TopIntroductionMeasurements of Alcohol...Relation Between Alcohol...Protective Effects of Alcohol...Mechanisms for Cardioprotective...RecommendationsReferences |
|---|
1. Moore RD, Pearson TA. Moderate alcohol consumption and coronary artery disease: a review. Medicine (Baltimore).. 1986;65:242-267.[Medline] [Order article via Infotrieve]
2.
Pearson TA, Terry P. What to advise patients about drinking alcohol: the clinician's conundrum. JAMA.. 1994;272:967-968. Editorial.
3.
Friedman GD, Klatsky AL. Is alcohol good for your health? N Engl J Med.. 1993;329:1882-1883. Editorial.
4. Provisional Table on the Nutrient Content of Beverages. Washington, DC: Department of Agriculture, Human Nutrition Information Service, 1982.
5. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med.. 1992;117:646-654.
6. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet.. 1991;338:464-468.[Medline] [Order article via Infotrieve]
7. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med.. 1988;319:267-273.[Abstract]
8.
Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, Hunter DJ, Hankinson SE, Hennekens CH, Rosner B. Alcohol consumption and mortality among women. N Engl J Med.. 1995;332:1245-1250.
9. Colditz GA, Branch LG, Lipnick RJ, Willett WC, Rosner B, Posner B, Hennekens CH. Moderate alcohol and decreased cardiovascular mortality in an elderly cohort. Am Heart J.. 1985;109:886-889.[Medline] [Order article via Infotrieve]
10.
Bradley KA, Donovan DM, Larson EB. How much is too much? Advising patients about safe levels of alcohol consumption. Arch Intern Med.. 1993;153:2734-2740.
11.
McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA.. 1993;270:2207-2212.
12. Diamond I. Alcoholic myopathy and cardiomyopathy. N Engl J Med.. 1989;320:458-460. Editorial.[Medline] [Order article via Infotrieve]
13. Klatsky AL, Friedman GD, Siegelaub AB, Gerard MJ. Alcohol consumption and blood pressure: Kaiser-Permanente Multiphasic Health Examination data. N Engl J Med.. 1977;296:1194-1200.[Abstract]
14.
Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in relation to consumption of alcohol: 13 years' observations in male British doctors. BMJ.. 1994;309:911-918.
15.
Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med.. 1993;329:1829-1834.
16. Klatsky A, Armstrong M, Friedman G. Risk of cardiovascular mortility in alcohol drinkers, ex-drinkers, and non-drinkers. Am J Cardiol. 1990;66:1237-1242.[Medline] [Order article via Infotrieve]
17. Gordon T, Ernst N, Fisher M, Rifkind BM. Alcohol and high-density lipoprotein cholesterol. Circulation. 1981;64(suppl III):III-63-III-67.
18. Hulley SB, Gordon S. Alcohol and high-density lipoprotein cholesterol: causal inference from diverse study designs. Circulation. 1981;64(suppl III):III-57-III-63.
19. Haskell WL, Camargo C Jr, Williams PT,Vranizan KM, Krauss RM, Lindgren FT, Wood PD. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions: a controlled study. N Engl J Med.. 1984;310:805-810.[Abstract]
20. Moore RD, Smith CR, Kwiterovich PO, Pearson TA. Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B. Am J Med.. 1988;84:884-890.[Medline] [Order article via Infotrieve]
21. Suh I, Shaten BJ, Cutler JA, Kuller LH, for the Multiple Risk Factor Intervention Trial research group. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. Ann Intern Med.. 1992;116:881-887.
22.
Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, Cohn R. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results from the Lipid Research Clinics Follow-up Study. Am J Epidemiol.. 1987;126:629-637.
23.
Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA.. 1994;272:929-933.
24. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet.. 1992;339:1523-1526.[Medline] [Order article via Infotrieve]
25.
Goldberg DM. Does wine work? Clin Chem.. 1995;41:14-16. Editorial.
26. Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity in serum. Lancet.. 1994;344:193-194. Letter.
27.
Whitehead TP, Robinson D, Allaway S, Syms J, Hale A. Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem.. 1995;41:32-35.
28.
Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? BMJ.. 1996;312:731-736.
29. Jackson R, Beaglehole R. Alcohol consumption guidelines: relative safety vs absolute risks and benefits. Lancet.. 1995;346:716. Commentary.[Medline] [Order article via Infotrieve]
30. Lieber CS. To drink (moderately) or not to drink? N Engl J Med.. 1984;310:846-848. Editorial.[Medline] [Order article via Infotrieve]
31.
Stampfer MJ, Rimm EB, Walsh DC. Commentary: alcohol, the heart, and public policy. Am J Public Health.. 1993;83:801-804.
32.
Peele S. The conflict between public health goals and the temperance mentality. Am J Public Health.. 1993;83:805-810.
This article has been cited by other articles:
 |
|
 |
|
  M T Streppel, M C Ocke, H C Boshuizen, F J Kok, and D Kromhout Long-term wine consumption is related to cardiovascular mortality and life expectancy independently of moderate alcohol intake: the Zutphen Study J Epidemiol Community Health, July 1, 2009; 63(7): 534 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Lauer and P. Sorlie Alcohol, Cardiovascular Disease, and Cancer: Treat With Caution J Natl Cancer Inst, March 4, 2009; 101(5): 282 - 283. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Vlasoff, T. Laatikainen, V. Korpelainen, M. Uhanov, S. Pokusajeva, A. Rogacheva, K. Tossavainen, E. Vartiainen, and P. Puska Ten year trends in chronic disease risk factors in the Republic of Karelia, Russia Eur J Public Health, December 1, 2008; 18(6): 666 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Morrow, J. P. Cullen, P. A. Cahill, and E. M. Redmond Ethanol stimulates endothelial cell angiogenic activity via a Notch- and angiopoietin-1-dependent pathway Cardiovasc Res, July 15, 2008; 79(2): 313 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Lichtenstein, L. J. Appel, M. Brands, M. Carnethon, S. Daniels, H. A. Franch, B. Franklin, P. Kris-Etherton, W. S. Harris, B. Howard, et al. Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee Circulation, July 4, 2006; 114(1): 82 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Cullen, S. Sayeed, Y. Jin, N. G. Theodorakis, J. V. Sitzmann, P. A. Cahill, and E. M. Redmond Ethanol inhibits monocyte chemotactic protein-1 expression in interleukin-1{beta}-activated human endothelial cells Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1669 - H1675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Lucas, R. A. Brown, M. Wassef, and T. D. Giles Alcohol and the Cardiovascular System: Research Challenges and Opportunities J. Am. Coll. Cardiol., June 21, 2005; 45(12): 1916 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Costanza, E. Cayanis, B. M. Ross, M. S. Flaherty, G. B. Alvin, K. Das, and A. Morabia Relative Contributions of Genes, Environment, and Interactions to Blood Lipid Concentrations in a General Adult Population Am. J. Epidemiol., April 15, 2005; 161(8): 714 - 724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C.M. Appeldoorn, A. Bonnefoy, B. C.H. Lutters, K. Daenens, T. J.C. van Berkel, M. F. Hoylaerts, and E. A.L. Biessen Gallic Acid Antagonizes P-Selectin-Mediated Platelet-Leukocyte Interactions: Implications for the French Paradox Circulation, January 4, 2005; 111(1): 106 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Vita Polyphenols and cardiovascular disease: effects on endothelial and platelet function Am. J. Clinical Nutrition, January 1, 2005; 81(1): 292S - 297S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M de Lorgeril and P Salen Is alcohol anti-inflammatory in the context of coronary heart disease? Heart, April 1, 2004; 90(4): 355 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M N Zairis, J A Ambrose, A G Lyras, M A Thoma, P K Psarogianni, P G Psaltiras, A D Kardoulas, G P Bibis, E G Pissimissis, P C Batika, et al. C Reactive protein, moderate alcohol consumption, and long term prognosis after successful coronary stenting: four year results from the GENERATION study Heart, April 1, 2004; 90(4): 419 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Morabia, E. Cayanis, M. C. Costanza, B. M. Ross, M. S. Flaherty, G. B. Alvin, K. Das, and T. C. Gilliam Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors Hum. Mol. Genet., November 1, 2003; 12(21): 2733 - 2743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Laatikainen, L Manninen, K Poikolainen, and E Vartiainen Increased mortality related to heavy alcohol intake pattern J Epidemiol Community Health, May 1, 2003; 57(5): 379 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Sekikawa, B Y Horiuchi, D Edmundowicz, H Ueshima, J D Curb, K Sutton-Tyrrell, T Okamura, T Kadowaki, A Kashiwagi, K Mitsunami, et al. A "natural experiment" in cardiovascular epidemiology in the early 21st century Heart, March 1, 2003; 89(3): 255 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Vogel Vintners and vasodilators: are French red wines more cardioprotective? J. Am. Coll. Cardiol., February 5, 2003; 41(3): 479 - 481. [Full Text] [PDF]
|
|
|
|
|
|
M. de Lorgeril, P. Salen, J.-L. Martin, F. Boucher, F. Paillard, and J. de Leiris Wine Drinking and Risks of Cardiovascular Complications After Recent Acute Myocardial Infarction Circulation, September 17, 2002; 106(12): 1465 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamaguchi, C. Dayton, T. Shigematsu, P. Carter, T. Yoshikawa, D. C. Gute, and R. J. Korthuis Preconditioning with ethanol prevents postischemic leukocyte-endothelial cell adhesive interactions Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1019 - H1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Cooper, D. C. Goff Jr., R. A. Bell, D. Zaccaro, E. J. Mayer-Davis, and A. J. Karter Is Insulin Sensitivity a Causal Intermediate in the Relationship Between Alcohol Consumption and Carotid Atherosclerosis?: The Insulin Resistance and Atherosclerosis Study Diabetes Care, August 1, 2002; 25(8): 1425 - 1431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Pearson, S. N. Blair, S. R. Daniels, R. H. Eckel, J. M. Fair, S. P. Fortmann, B. A. Franklin, L. B. Goldstein, P. Greenland, S. M. Grundy, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases Circulation, July 16, 2002; 106(3): 388 - 391. [Full Text] [PDF]
|
|
|
|
|
|
M. de Lorgeril, P. Salen, F. Paillard, F. Laporte, F. Boucher, and J. de Leiris Mediterranean diet and the French paradox: Two distinct biogeographic concepts for one consolidated scientific theory on the role of nutrition in coronary heart disease Cardiovasc Res, June 1, 2002; 54(3): 503 - 515. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Laatikainen, H. Alho, E. Vartiainen, P. Jousilahti, P. Sillanaukee, and P. Puska SELF-REPORTED ALCOHOL CONSUMPTION AND ASSOCIATION TO CARBOHYDRATE-DEFICIENT TRANSFERRIN AND GAMMA-GLUTAMYLTRANSFERASE IN A RANDOM SAMPLE OF THE GENERAL POPULATION IN THE REPUBLIC OF KARELIA, RUSSIA AND IN NORTH KARELIA, FINLAND Alcohol Alcohol., May 1, 2002; 37(3): 282 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Allen, J. Markovitz, D. R. Jacobs Jr., and S. S. Knox Social Support and Health Behavior in Hostile Black and White Men and Women in CARDIA Psychosom Med, July 1, 2001; 63(4): 609 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-W. Gu, J. Elam, A. Sartin, W. Li, R. Roach, and T. H. Adair Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R365 - R372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Corella, K. Tucker, C. Lahoz, O. Coltell, L A. Cupples, P. W. Wilson, E. J Schaefer, and J. M Ordovas Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study Am. J. Clinical Nutrition, April 1, 2001; 73(4): 736 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. J. Goldberg, L. Mosca, M. R. Piano, and E. A. Fisher Wine and Your Heart : A Science Advisory for Healthcare Professionals From the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association Stroke, February 1, 2001; 32(2): 591 - 594. [Full Text] [PDF]
|
|
|
|
|
|
I. J. Goldberg, L. Mosca, M. R. Piano, and E. A. Fisher Wine and Your Heart : A Science Advisory for Healthcare Professionals From the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association Circulation, January 23, 2001; 103(3): 472 - 475. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Malarcher, W. H. Giles, J. B. Croft, M. A. Wozniak, R. J. Wityk, P. D. Stolley, B. J. Stern, M. A. Sloan, R. Sherwin, T. R. Price, et al. Alcohol Intake, Type of Beverage, and the Risk of Cerebral Infarction in Young Women Stroke, January 1, 2001; 32(1): 77 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Scientific Statement: AHA Dietary Guidelines: Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association J. Nutr., January 1, 2001; 131(1): 132 - 146. [Full Text]
|
|
|
|
|
|
E. R. De Oliveira e Silva, D. Foster, M. McGee Harper, C. E. Seidman, J. D. Smith, J. L. Breslow, and E. A. Brinton Alcohol Consumption Raises HDL Cholesterol Levels by Increasing the Transport Rate of Apolipoproteins A-I and A-II Circulation, November 7, 2000; 102(19): 2347 - 2352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association Stroke, November 1, 2000; 31(11): 2751 - 2766. [Full Text] [PDF]
|
|
|
|
|
|
R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association Circulation, October 31, 2000; 102(18): 2284 - 2299. [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Sesso, M. J. Stampfer, B. Rosner, C. H. Hennekens, J. E. Manson, and J. M. Gaziano Seven-Year Changes in Alcohol Consumption and Subsequent Risk of Cardiovascular Disease in Men Arch Intern Med, September 25, 2000; 160(17): 2605 - 2612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Weintraub Alcohol Consumption, Diabetes, and Coronary Disease : An Epidemiological Perspective Circulation, August 1, 2000; 102(5): 489 - 490. [Full Text] [PDF]
|
|
|
|
|
|
U. A. Ajani, J. M. Gaziano, P. A. Lotufo, S. Liu, C. H. Hennekens, J. E. Buring, and J. E. Manson Alcohol Consumption and Risk of Coronary Heart Disease by Diabetes Status Circulation, August 1, 2000; 102(5): 500 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Cooper, D. V. Exner, and M. J. Domanski Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1753 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fauchier, D. Babuty, P. Poret, D. Casset-Senon, M.L. Autret, P. Cosnay, and J.P. Fauchier Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy Eur. Heart J., February 2, 2000; 21(4): 306 - 314. [Abstract] [PDF]
|
|
|
|
|
|
H. J. Pownall, C. M. Ballantyne, K. T. Kimball, S. L. Simpson, D. Yeshurun, and A. M. Gotto Jr Effect of Moderate Alcohol Consumption on Hypertriglyceridemia: A Study in the Fasting State Arch Intern Med, May 10, 1999; 159(9): 981 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Enas Alcohol and Cardiovascular Mortality in US Physicians: Is There a Modifier Effect by Low-Density Lipoprotein? Arch Intern Med, August 11, 1997; 157(15): 1769 - 1770. [Abstract] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||